In an interview with The Clinical Trial Vanguard, Phastar CEO Graham Clark explores the evolving pharmaceutical landscape. He shares insights on the latest industry trends, highlighting the growing role of technology in clinical trials and the strategic advancements shaping drug development and trial management.
”The industry is at a pivotal moment where embracing technological advancements and adapting to new market dynamics will determine success. It’s an exciting time for pharma, with many opportunities for those who can navigate these changes effectively.”